# Lendormin D® Tablet (Drug Use Result Survey)

> **NCT02224014** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 485 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** Lendormin D tablets

## Key facts

- **NCT ID:** NCT02224014
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-03
- **Final completion:** —
- **Target enrollment:** 485 (ACTUAL)
- **Last updated:** 2014-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02224014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02224014, "Lendormin D® Tablet (Drug Use Result Survey)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02224014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*